This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Coty (COTY) Focuses on Boosting Global Presence, Ups FY23 View
by Zacks Equity Research
Coty (COTY) is hosting its first investor event in Paris, wherein it is set to provide details regarding the financial performance, operating landscape and growth agenda. It is also raising guidance.
Hormel Foods (HRL) Exhibits Solid Prospects Despite Risks
by Zacks Equity Research
Hormel Foods (HRL) is poised to benefit from its business strength, strategic investments and acquisitions. However, supply-chain inefficiencies remain concerning.
Estee Lauder (EL) Gains From Emerging Market Presence Amid Risks
by Zacks Equity Research
Estee Lauder (EL) is poised to benefit from its online business, investments in new technology and digital experiences, as well as its strength in emerging markets. However, high operating expenses remain a concern.
Why You Must Consider Colgate (CL) Stock Before Q2 Earnings
by Zacks Equity Research
Colgate (CL) is well-poised on its innovation efforts, pricing actions, digital capabilities and progress on revenue growth management initiatives.
Clorox (CLX) Surpasses the Industry in a Year: Here's How
by Zacks Equity Research
Clorox (CLX) is poised to benefit from pricing gains and cost savings efforts, along with a solid innovation pipeline, digital transformation and its IGNITE strategy.
Here's Why Procter & Gamble (PG) is an Attractive Pick Now
by Zacks Equity Research
Procter & Gamble (PG) is a lucrative pick on its ongoing business momentum, strength across businesses, pricing actions and productivity plans.
Watch These 4 Cosmetics Stocks as Industry Looks Radiant
by Zacks Equity Research
The Zacks Cosmetics industry players benefit from their focus on innovation and online strength amid favorable demand. Coty (COTY), el.f. Beauty (ELF), Inter Parfums (IPAR) and Helen of Troy (HELE) look well-placed.
Are Consumer Staples Stocks Lagging Clorox (CLX) This Year?
by Zacks Equity Research
Here is how Clorox (CLX) and Coty (COTY) have performed compared to their sector so far this year.
Colgate (CL) Looks Solid on Pricing Action & Expansion Strategy
by Zacks Equity Research
Pricing actions, revenue management initiatives, innovation, brand strength and digital growth position Colgate (CL) for growth amid higher costs and currency headwinds.
Here's Why You Should Consider Investing in COTY Stock Now
by Zacks Equity Research
COTY is poised to benefit from its focus on six strategic pillars, strength across its businesses, acquisitions and cost management efforts.
This Top Consumer Staples Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
by Zacks Equity Research
The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Why Is Coty (COTY) Down 0.3% Since Last Earnings Report?
by Zacks Equity Research
Coty (COTY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
International Flavors (IFF) Divests Savory Solutions Business
by Zacks Equity Research
International Flavors & Fragrances (IFF) divests its underperforming Savory Solutions Group and intends to utilize the proceeds to lower debt levels.
Is Coty (COTY) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Coty (COTY) and Coca-Cola FEMSA (KOF) have performed compared to their sector so far this year.
New Strong Buy Stocks for May 31st
by Zacks Equity Research
COTY, GFI, CAJPY, AMR and MUSA have been added to the Zacks Rank #1 (Strong Buy) List on May 31, 2023.
Should Invesco FTSE RAFI US 1500 Small-Mid ETF (PRFZ) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for PRFZ
Why Coty (COTY) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Zacks Analyst Blog Highlights Celsius Holdings, The Clorox, Lamb Weston Holdings, Coty and Inter Parfums
by Zacks Equity Research
Celsius Holdings, The Clorox, Lamb Weston Holdings, Coty and Inter Parfums are part of the Zacks top Analyst Blog.
Are Consumer Staples Stocks Lagging Coty (COTY) This Year?
by Zacks Equity Research
Here is how Coty (COTY) and Coca-Cola FEMSA (KOF) have performed compared to their sector so far this year.
U.S. Consumer Sentiment Tumbles in May: 5 Safe Stocks to Buy
by Nalak Das
We have narrowed our search to five consumer staples stocks . These are: CELH, CLX, COTY, LW and IPAR.
5 Top Stocks Likely to Exceed Earnings Estimates
by Sanghamitra Saha
These top-ranked stocks are likely to beat on bottom line in their next releases. Tap Clorox (CLX), Coty (COTY), Yum China (YUMC), Terex (TEX) and Martin Marietta Materials (MLM).
Best Growth Stocks to Buy for May 12th
by Zacks Equity Research
COTY, IFNNY and PHM made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 12, 2023.
COTY Beats Earnings Estimates in Q3, Raises 2023 Guidance
by Zacks Equity Research
COTY third-quarter fiscal 2023 results reflect improved earnings and sales on gains from Prestige & Consumer Beauty business.
Coty (COTY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Coty (COTY) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Coty (COTY) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Coty (COTY) delivered earnings and revenue surprises of 533.33% and 5.42%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?